Literature DB >> 34085110

Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation: three case reports.

Seunghee Na1, Taewon Kim2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34085110     DOI： 10.1007/s10072-021-05368-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  9 in total

1.  Monorhythmic frontal delta activity in the human electroencephalogram: a study of 100 cases.

Authors:  J P CORDEAU
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1959-11

2.  A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.

Authors:  M Strupp; R Kalla; J Claassen; C Adrion; U Mansmann; T Klopstock; T Freilinger; H Neugebauer; R Spiegel; M Dichgans; F Lehmann-Horn; K Jurkat-Rott; T Brandt; J C Jen; K Jahn
Journal:  Neurology       Date:  2011-07-06       Impact factor: 9.910

3.  [Editorial: Medical ethics in medical care services].

Authors:  P Kassab
Journal:  AMB Rev Assoc Med Bras       Date:  1973-12

4.  Effectiveness of levetiracetam in an acetazolamide-unresponsive patient with episodic ataxia type 2 by a novel CACNA1A nonsense mutation.

Authors:  H Lee; D-H Jang; J-H Jang; T Kim
Journal:  Eur J Neurol       Date:  2017-07       Impact factor: 6.089

5.  Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2.

Authors:  Elide Mantuano; Silvia Romano; Liana Veneziano; Cinzia Gellera; Barbara Castellotti; Sara Caimi; Daniela Testa; Margherita Estienne; Giovanna Zorzi; Marianna Bugiani; Yusuf A Rajabally; Maria J Garcìa Barcina; Serena Servidei; Aurora Panico; Marina Frontali; Caterina Mariotti
Journal:  J Neurol Sci       Date:  2010-02-02       Impact factor: 3.181

6.  Episodic ataxia type 2 manifests as epileptiform electroencephalographic activity with no epileptic attacks in two family members.

Authors:  Misako Kaido; Mitsuru Furuta; Masayuki Nakamori; Yoshihito Yuasa; Masanori P Takahashi
Journal:  Rinsho Shinkeigaku       Date:  2016-03-30

7.  Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.

Authors:  Sanjeev Rajakulendran; Tracey D Graves; Robyn W Labrum; Dimitrios Kotzadimitriou; Louise Eunson; Mary B Davis; Rosalyn Davies; Nicholas W Wood; Dimitri M Kullmann; Michael G Hanna; Stephanie Schorge
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

8.  Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients.

Authors:  Jihye Park; Hyun Mi Oh; Hye Jung Park; Ah-Ra Cho; Dong-Woo Lee; Ja-Hyun Jang; Dae-Hyun Jang
Journal:  Mol Genet Genomic Med       Date:  2019-09-01       Impact factor: 2.183

9.  Clinical and imaging correlates of EEG patterns in hospitalized patients with encephalopathy.

Authors:  Raoul Sutter; Robert D Stevens; Peter W Kaplan
Journal:  J Neurol       Date:  2012-11-30       Impact factor: 4.849
  9 in total
  1 in total

1.  The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2.

Authors:  Cristina González-Mingot; Ricard López-Ortega; Luis Brieva-Ruiz
Journal:  Neurol Sci       Date:  2022-05-20       Impact factor: 3.830
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.